当研究室(遺伝子治療・再生医学分野)では、再生医療、遺伝子治療、バイオテクノロジーと先端医学開発の研究を行っています。

論文 - 鹿児島大学大学院医歯学総合研究科 先進治療科学専攻 運動機能修復学講座 遺伝子治療・再生医学分野

4

Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T, Inoue S.
Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.

 

Horm Cancer 3: 147-159, 2012

 


 

 

pediatr  Murakami KI, Kaji T, Shimono R, Hyashida Y, Matsufuji H, Tsuyama S,
  Maezono R, Kosai K, Takamatsu H.

  Therapeutic effects of vitamin A on experimental cholestatic rats with
  hepatic fibrosis.

 

  Pediatr Surg Int. 27(8):863-70, 2011
 


 

home cancer

Shigekawa T, Ijichi N, Ikeda K, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T, Inoue S.
FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer.

 

Horm Cancer. 2: 286-297. 2011


 

j steroid biochem mol biol

Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Fujimura T, Tsuda H, Osaki A, Saeki T, Inoue S.

Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer.

 

J Steroid Biochem Mol Biol. 123: 1-7. 2011

 


 

biochem. biophys. res. commun  Kamisasanuki T, Wang Y, Tokushige S, Terasaki H, Khai NC, Wang Y,
  Sakamoto T, Kosai K.

  Targeting CD9 produces stimulus-independent antiangiogenic effects
  predominantly in activated endothelial cells during angiogenesis: A novel
  antiangiogenic therapy.

 

                         Biochem. Biophys. Res. Commun. 16;413(1):128-35, 2011  

 


 

cas.2010.101.issue 3.cover Horikawa Y, Wang Y, Nagano S, Kamizono J, Ikeda M, Komiya S, Kosai K.

 Assessment of an altered E1B promoter on the specificity and potency of
 triple-regulated conditionally replicating adenoviruses (CRA) ⎯Implications
 for the generation of ideal m-CRAs.

 

 Cancer Gene Ther 18(10):724-33, 2011

 


 

hep.2011.41.issue 6.cover Khai NC, Sakamoto K, Takamatsu H, Matsufuji H, Kosai K.

 Recombinant soluble form of HB-EGF protein therapy drastically
 inhibits Fas-mediated fulminant hepatic failure: Implications in clinical
 application.

 

 Hepatol Res. 41:594-596, 2011.
 

 


 

8

 Murakami KI, Kaji T, Shimono R, Hyashida Y, Matsufuji H, Tsuyama S,
  Maezono R, Kosai K, Takamatsu H.

  Therapeutic effects of vitamin A on experimental cholestatic rats with
  hepatic fibrosis.

 

  Pediatr Surg Int. 27(8):863-70, 2011. 
 


 

cas.2010.101.issue 3.cover

Fujimura T, Takahashi S, Urano T, Ijichi N, Ikeda K, Kumagai J, Murata T, Takayama K, Horie-Inoue K, Ouchi Y, Muramatsu M, Homma Y, Inoue S.
Differential expression of estrogen-related receptors β and γ (ERRβ and ERRγ) and their clinical significance in human prostate cancer.

 

Cancer Sci. 101: 646-651, 2010

 


 

brian reseach Okabe Y, Kusanaga A, Takahashi T, Mitsumasu C, Murai Y, Tanaka E,
 Higashi H, Matsuishi T, Kosai K.

 Neural Development of Methyl-CpG-Binding Protein 2 Null Embryonic Stem
 Cells: A System for Studying Rett Syndrome.

 

 Brain Res. 1360(11): 17-27, 2010

  


 

業績・特許・研究費

大学院生・スタッフ募集

https://oncolo.jp/ct/ad/ad0038

鹿児島大学大学院医歯学総合研究科 遺伝子治療・再生医学分野

医学部基礎研究棟3階
(エレベーターを出てから左の教室です)

鹿児島県鹿児島市桜ヶ丘8丁目35-1
TEL.099-275-5219
FAX.099-265-9721

このページのTOPへ